Ocular Tissue Engineering: Current and Future Directions

Tissue engineering (TE) is a concept that was first emerged in the early 1990s to provide solutions to severe injured tissues and/or organs [1]. The dream was to be able to restore and replace the damaged tissue with an engineered version which would ultimately help overcome problems such as donor s...

Full description

Bibliographic Details
Main Author: D. Karamichos
Format: Article
Language:English
Published: MDPI AG 2015-02-01
Series:Journal of Functional Biomaterials
Subjects:
n/a
Online Access:http://www.mdpi.com/2079-4983/6/1/77
id doaj-d0ddf82fa6e54ed3b4da185191b784a5
record_format Article
spelling doaj-d0ddf82fa6e54ed3b4da185191b784a52020-11-25T00:53:17ZengMDPI AGJournal of Functional Biomaterials2079-49832015-02-0161778010.3390/jfb6010077jfb6010077Ocular Tissue Engineering: Current and Future DirectionsD. Karamichos0Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USATissue engineering (TE) is a concept that was first emerged in the early 1990s to provide solutions to severe injured tissues and/or organs [1]. The dream was to be able to restore and replace the damaged tissue with an engineered version which would ultimately help overcome problems such as donor shortages, graft rejections, and inflammatory responses following transplantation. While an incredible amount of progress has been made, suggesting that TE concept is viable, we are still not able to overcome major obstacles. In TE, there are two main strategies that researchers have adopted: (1) cell-based, where cells are been manipulated to create their own environment before transplanted to the host, and (2) scaffold-based, where an extracellular matrix is created to mimic in vivo structures. TE approaches for ocular tissues are available and have indeed come a long way, over the last decades; however more clinically relevant ocular tissue substitutes are needed. Figure 1 highlights the importance of TE in ocular applications and indicates the avenues available based on each tissue.[...]http://www.mdpi.com/2079-4983/6/1/77n/a
collection DOAJ
language English
format Article
sources DOAJ
author D. Karamichos
spellingShingle D. Karamichos
Ocular Tissue Engineering: Current and Future Directions
Journal of Functional Biomaterials
n/a
author_facet D. Karamichos
author_sort D. Karamichos
title Ocular Tissue Engineering: Current and Future Directions
title_short Ocular Tissue Engineering: Current and Future Directions
title_full Ocular Tissue Engineering: Current and Future Directions
title_fullStr Ocular Tissue Engineering: Current and Future Directions
title_full_unstemmed Ocular Tissue Engineering: Current and Future Directions
title_sort ocular tissue engineering: current and future directions
publisher MDPI AG
series Journal of Functional Biomaterials
issn 2079-4983
publishDate 2015-02-01
description Tissue engineering (TE) is a concept that was first emerged in the early 1990s to provide solutions to severe injured tissues and/or organs [1]. The dream was to be able to restore and replace the damaged tissue with an engineered version which would ultimately help overcome problems such as donor shortages, graft rejections, and inflammatory responses following transplantation. While an incredible amount of progress has been made, suggesting that TE concept is viable, we are still not able to overcome major obstacles. In TE, there are two main strategies that researchers have adopted: (1) cell-based, where cells are been manipulated to create their own environment before transplanted to the host, and (2) scaffold-based, where an extracellular matrix is created to mimic in vivo structures. TE approaches for ocular tissues are available and have indeed come a long way, over the last decades; however more clinically relevant ocular tissue substitutes are needed. Figure 1 highlights the importance of TE in ocular applications and indicates the avenues available based on each tissue.[...]
topic n/a
url http://www.mdpi.com/2079-4983/6/1/77
work_keys_str_mv AT dkaramichos oculartissueengineeringcurrentandfuturedirections
_version_ 1725238359426596864